Vyvanse caps 60MG
Ended Awarded Last action
- Contract number
- SPE2D826FBJ33
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $23,989
Award facts
- Contract value 100% obligated
- $23,989.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Vyvanse capsules (60 mg) with a ceiling value of $23,989.41. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and completion is scheduled for November 28, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems. The company's SPE2DX global pharmaceutical support contract enables it to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. Through this delivery order structure, AmerisourceBergen fulfills medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with this particular order addressing the supply of Vyvanse, a controlled pharmaceutical used in the treatment of attention-deficit/hyperactivity disorder.
Quick answers
Who was awarded contract SPE2D826FBJ33?
SPE2D826FBJ33 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on November 26, 2025.
How much is contract SPE2D826FBJ33 worth?
The government has obligated $23,989 on SPE2D826FBJ33.
Is contract SPE2D826FBJ33 an order under another contract?
Yes. SPE2D826FBJ33 is a delivery order under SPE2DX22D0010, an indefinite delivery contract.
Was contract SPE2D826FBJ33 competed?
The extent of competition for SPE2D826FBJ33 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award